<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    oju
   </journal-id>
   <journal-title-group>
    <journal-title>
     Open Journal of Urology
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2160-5440
   </issn>
   <issn publication-format="print">
    2160-5629
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/oju.2024.148047
   </article-id>
   <article-id pub-id-type="publisher-id">
    oju-135385
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    Socio-Demographic and Clinical Characteristics of Patients Presenting with Lower Urinary Tract Symptoms Secondary to BPH, in a Tertiary Hospital
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Abdul-Jalilu Mohammed
      </surname>
      <given-names>
       Muntaka
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Edwin Mwintiereh Ta-Ang
      </surname>
      <given-names>
       Yenli
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Francis Atindaana
      </surname>
      <given-names>
       Abantanga
      </given-names>
     </name> 
     <xref ref-type="aff" rid="aff1"> 
      <sup>1</sup>
     </xref> 
     <xref ref-type="aff" rid="aff2"> 
      <sup>2</sup>
     </xref>
    </contrib>
   </contrib-group> 
   <aff id="aff1">
    <addr-line>
     aDepartment of Surgery, School of Medicine, University for Development Studies, Tamale, Ghana
    </addr-line> 
   </aff> 
   <aff id="aff2">
    <addr-line>
     aDepartment of Surgery, Tamale Teaching Hospital, Tamale, Ghana
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     13
    </day> 
    <month>
     08
    </month>
    <year>
     2024
    </year>
   </pub-date> 
   <volume>
    14
   </volume> 
   <issue>
    08
   </issue>
   <fpage>
    447
   </fpage>
   <lpage>
    457
   </lpage>
   <history>
    <date date-type="received">
     <day>
      28,
     </day>
     <month>
      May
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="published">
     <day>
      18,
     </day>
     <month>
      May
     </month>
     <year>
      2024
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      18,
     </day>
     <month>
      August
     </month>
     <year>
      2024
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    <b>Background</b>
    <b>:</b> Benign prostatic hyperplasia (BPH) is the proliferation of the stromal and epithelial cells of the prostate gland, resulting in an increase in its size. This may result in obstruction of the lower urinary tract causing storage and voiding symptoms. 
    <b>Methods</b>
    <b>:</b> This was a prospective cross-sectional study from August 2020 to July 2021, to evaluate the characteristic of patients presenting to the Tamale Teaching Hospital with lower urinary tract symptoms secondary to BPH. 
    <b>Results</b>
    <b>:</b> The median age at presentation with LUTS secondary to BPH is 68.88 ± 11.10 years with an average prostate volume of 70 g. The average time of presentation to the hospital is 5 months, mostly with moderate to severe symptoms. Correlation between Prostate volume (PV) and age yielded a positive relationship; however, this was not statistically significant, (r = 0.028, p-value = 0.747). There was a significant positive relationship between PV and the IPSS score, (r = 0.334, p-value &lt; 0.001). 
    <b>Conclusion</b>
    <b>:</b> Our patients with symptomatic BPH present at age 60 years and above, with nearly all of them presenting with moderate to severe LUTS.
   </abstract>
   <kwd-group> 
    <kwd>
     Benign Prostate Hyperplasia
    </kwd> 
    <kwd>
      Lower Urinary Tract Symptoms
    </kwd> 
    <kwd>
      Sociodemographic Characteristics
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>The prostate gland is an accessory male sex organ located at the bladder neck and surrounds the first part of the male urethra <xref ref-type="bibr" rid="scirp.135385-1">
     [1]
    </xref>. In the non-diseased state, it measures 3 cm in length, 4 cm in width and 2 cm in depth, with an average volume of 15 - 20 cm<sup>3</sup> in adults <xref ref-type="bibr" rid="scirp.135385-2">
     [2]
    </xref>.</p>
   <p>In benign prostatic hyperplasia (BPH) there is proliferation of the stromal and epithelial cells of the prostate gland, resulting in an increase in size of the gland <xref ref-type="bibr" rid="scirp.135385-3">
     [3]
    </xref>. The increase in prostate size may result in compression of the urethra and subsequent bladder outlet obstruction. The effect of such an obstruction results in urinary voiding symptoms (straining, weak stream, intermittency and incomplete emptying) as well as urinary storage symptoms (frequency, urgency and nocturia). These storage and voiding symptoms are together referred to as lower urinary tract symptoms (LUTS) <xref ref-type="bibr" rid="scirp.135385-4">
     [4]
    </xref>.</p>
   <p>BPH is a common condition affecting most men over the age of 40 years worldwide, though not all patients will have symptoms <xref ref-type="bibr" rid="scirp.135385-5">
     [5]
    </xref>. In a meta-analysis to estimate the global burden of lower urinary tract symptoms secondary to BPH, Lee et al. <xref ref-type="bibr" rid="scirp.135385-6">
     [6]
    </xref> found a median prevalence of symptomatic BPH of 25.2% among 31 studies worldwide. The lowest was 12.0% in a Chinese study and the highest was 42% in a United States-based study <xref ref-type="bibr" rid="scirp.135385-6">
     [6]
    </xref>. Among West Africans, the prevalence of digital rectal examination (DRE) detected BPH is 62.3% <xref ref-type="bibr" rid="scirp.135385-7">
     [7]
    </xref>. However, the prevalence of lower urinary tract symptoms secondary to BPH in the West African sub-region has been estimated to be around 20% <xref ref-type="bibr" rid="scirp.135385-7">
     [7]
    </xref>.</p>
   <p>The northern part of Ghana is relatively young in medical practice by trained urologist. This study was aimed at evaluating the characteristics of patients presenting to a tertiary hospital with lower urinary tract symptoms secondary to BPH in northern Ghana.</p>
  </sec><sec id="s2">
   <title>2. Materials and Method</title>
   <p>A prospective cross-sectional study using convenience sampling was conducted at the Urology Unit in the Department of Surgery, Tamale Teaching Hospital (TTH). This is the largest and only teaching hospital serving the five regions of northern Ghana (Northern, North-East, Savanna, Upper West and Upper East Regions) with an estimated population of about 6 million <xref ref-type="bibr" rid="scirp.135385-8">
     [8]
    </xref>. Patients presenting with lower urinary tract symptoms secondary to BPH were recruited using non-probability convenience sampling. Sample size was determined based on the prevalence of BPH at TTH.</p>
   <p>Data was entered into Microsoft Excel 2016 version for cleaning, and analyzed using the Statistical Software for Social Sciences (SPSS, IBM) version 23. Spearman’s rho correlation was used to assess the relationship between prostate volume and parameters such as age, IPSS and PSA. Statistical significance was considered at a p-value of less than 0.05.</p>
  </sec><sec id="s3">
   <title>3. Results</title>
   <p>A total of 138 participants were recruited for this study. A majority of the participants (65.22%) were from the Northern Region of Ghana with a very large proportion of them in a low socioeconomic status (83.33%). Also, many participants (59.42%) practiced the Islamic religion. This is illustrated in <xref ref-type="table" rid="table1">
     Table 1
    </xref></p>
   <table-wrap id="table1">
    <label>
     <xref ref-type="table" rid="table1">
      Table 1
     </xref></label>
    <caption>
     <title>
      <xref ref-type="bibr" rid="scirp.135385-"></xref>Table 1. Socio-demographic characteristics of participants.</title>
    </caption>
    <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
     <tr> 
      <td class="custom-bottom-td acenter" width="40.08%">Variable<p style="text-align:center"></p></td> 
      <td class="custom-bottom-td acenter" width="32.06%">Frequency (n = 138)<p style="text-align:center"></p></td> 
      <td class="custom-bottom-td acenter" width="27.86%">Percentage (%)<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="custom-top-td acenter" width="40.08%">Place of Residence (Region)<p style="text-align:center"></p></td> 
      <td class="custom-top-td acenter" width="32.06%"><p style="text-align:center"></p></td> 
      <td class="custom-top-td acenter" width="27.86%"><p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Northern<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">90<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">65.22<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Upper East<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">32<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">23.19<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">North-East<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">6<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">4.35<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Savannah<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">5<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">3.62<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Upper West<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">2<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">1.45<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Oti<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">2<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">1.45<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Ashanti<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">1<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">0.72<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Socioeconomic Status<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%"><p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%"><p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Low<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">115<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">83.33<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Middle<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">21<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">15.22<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">High<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">2<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">1.45<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Religion<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%"><p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%"><p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Islam<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">82<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">59.42<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Christianity<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">54<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">39.13<p style="text-align:center"></p></td> 
     </tr> 
     <tr> 
      <td class="acenter" width="40.08%">Traditional<p style="text-align:center"></p></td> 
      <td class="acenter" width="32.06%">2<p style="text-align:center"></p></td> 
      <td class="acenter" width="27.86%">1.45<p style="text-align:center"></p></td> 
     </tr> 
    </table>
   </table-wrap>
   <sec id="s3_1">
    <title>3.1. Baseline Clinical Characteristics of the Study Subjects</title>
    <p>There were 138 participants in this study with a mean age of 68.88 ± 11.10 years. The mean duration of symptoms before patients presented to the hospital was 4.80 (±1.99) months. The mean body mass index of the study participants was 23.50 (±2.67) kg/m<sup>2</sup> and the mean waist circumference was 91.25 (±5.42) cm. The mean prostate volume of the participants was 68.28 (±15.03) cm<sup>3</sup>, and the mean PSA was 2.65 (±0.90) ng/ml. Refer to <xref ref-type="table" rid="table2">
      Table 2
     </xref>.</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.135385-"></xref>Table 2. Baseline characteristics of study subjects (n = 138).</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="27.27%">Variable (n = 138)<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="21.34%">Minimum<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="25.11%">Maximum<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="26.27%">Mean ± SD<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="27.27%">Age (years)<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="21.34%">42<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="25.11%">100<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="26.27%">68.88 ± 11.10<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="27.27%">BMI (kg/m<sup>2</sup>)<p style="text-align:center"></p></td> 
       <td class="acenter" width="21.34%">18.50<p style="text-align:center"></p></td> 
       <td class="acenter" width="25.11%">30.10<p style="text-align:center"></p></td> 
       <td class="acenter" width="26.27%">23.50 ± 2.67<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="27.27%">WC (cm)<p style="text-align:center"></p></td> 
       <td class="acenter" width="21.34%">82.2<p style="text-align:center"></p></td> 
       <td class="acenter" width="25.11%">109.3<p style="text-align:center"></p></td> 
       <td class="acenter" width="26.27%">91.25 ± 5.42<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="27.27%">DOS (months)<p style="text-align:center"></p></td> 
       <td class="acenter" width="21.34%">1<p style="text-align:center"></p></td> 
       <td class="acenter" width="25.11%">10<p style="text-align:center"></p></td> 
       <td class="acenter" width="26.27%">4.80 ± 1.99<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="27.27%">PSA (ng/ml)<p style="text-align:center"></p></td> 
       <td class="acenter" width="21.34%">0.25<p style="text-align:center"></p></td> 
       <td class="acenter" width="25.11%">4.0<p style="text-align:center"></p></td> 
       <td class="acenter" width="26.27%">2.65 ± 0.90<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="27.27%">PV (cm<sup>3</sup>)<p style="text-align:center"></p></td> 
       <td class="acenter" width="21.34%">37.90<p style="text-align:center"></p></td> 
       <td class="acenter" width="25.11%">106.70<p style="text-align:center"></p></td> 
       <td class="acenter" width="26.27%">68.28 ± 15.03<p style="text-align:center"></p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>The commonest comorbidity among study participants was hypertension constituting a total of 31.20%, either existing alone or in combination with other comorbidities, such as diabetes mellitus and/or hypercholesterinemia (<xref ref-type="fig" rid="fig1">
      Figure 1
     </xref>).</p>
    <fig id="fig1" position="float">
     <label>Figure 1</label>
     <caption>
      <title>Figure 1. Comorbidities in the study population.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/5000823-rId17.jpeg?20240823024518" />
    </fig>
   </sec>
   <sec id="s3_2">
    <title>3.2. Categorization of Lower Urinary Tract Symptoms Using the IPSS and QOL Score</title>
    <p>Nearly all study participants reported moderate to severe lower urinary tract symptoms using the International Prostate Symptom Score (98.50%). A majority of the participants were unhappy with their symptoms when assessed with a QoL score (65.90%), as shown in <xref ref-type="fig" rid="fig2">
      Figure 2
     </xref>.</p>
    <fig id="fig2" position="float">
     <label>Figure 2</label>
     <caption>
      <title>Figure 2. IPSS and QOL categorization among the study population.</title>
     </caption>
     <graphic mimetype="image" position="float" xlink:type="simple" xlink:href="https://html.scirp.org/file/5000823-rId18.jpeg?20240823024518" />
    </fig>
    <p>Spearman correlation was used to assess the correlation between PV and variables such as age, IPSS and PSA, and this is illustrated in <xref ref-type="table" rid="table3">
      Table 3
     </xref>. Correlation between PV and age yielded a positive relationship; however, this was not statistically significant, (r = 0.028, p-value = 0.747). There was a significant positive relationship between PV and the IPSS score, (r = 0.334, p-value &lt; 0.001), as well as PV and PSA (r = 0.383, p-value &lt; 0.001).</p>
    <p>Among those who had severe symptoms using the IPSS score, those within the ages of 60 to 79 years formed the majority (48.00%). This is shown in <xref ref-type="table" rid="table4">
      Table 4
     </xref> below.</p>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.135385-"></xref>Table 3. Relationship between PV and Age, IPSS score and PSA.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td acenter" width="16.64%"><p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="8.49%"><p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="29.09%"><p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="13.01%">Age<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="16.90%">IPSS score<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="15.87%">PSA<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td rowspan="3" class="custom-top-td acenter" width="16.64%">Spearman’s Rho<p style="text-align:center"></p></td> 
       <td rowspan="3" class="custom-top-td acenter" width="8.49%">PV<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="29.09%">Correlation Coefficient<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="13.01%">0.028<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="16.90%">0.334<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="15.87%">0.383<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="29.09%">p-value<p style="text-align:center"></p></td> 
       <td class="acenter" width="13.01%">0.747<p style="text-align:center"></p></td> 
       <td class="acenter" width="16.90%">0.000<p style="text-align:center"></p></td> 
       <td class="acenter" width="15.87%">0.000<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="29.09%">N<p style="text-align:center"></p></td> 
       <td class="acenter" width="13.01%">138<p style="text-align:center"></p></td> 
       <td class="acenter" width="16.90%">138<p style="text-align:center"></p></td> 
       <td class="acenter" width="15.87%">138<p style="text-align:center"></p></td> 
      </tr> 
     </table>
    </table-wrap>
    <table-wrap id="table4">
     <label>
      <xref ref-type="table" rid="table4">
       Table 4
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.135385-"></xref>Table 4. Distribution of IPSS according to age groups.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="29.54%"><p style="text-align:center"></p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="119.01%" colspan="4">IPSS GRADE<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td custom-top-td acenter" width="29.54%">Age Category<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="29.48%">Mild<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="29.88%">Moderate<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="29.48%">Severe<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td custom-top-td acenter" width="30.16%">Total<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td acenter" width="29.54%">40 - 59<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="29.48%">1 (50.00%)<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="29.88%">9 (10.47%)<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="29.48%">15 (30.00%)<p style="text-align:center"></p></td> 
       <td class="custom-top-td acenter" width="30.16%">25 (18.12%)<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="29.54%">60 - 79<p style="text-align:center"></p></td> 
       <td class="acenter" width="29.48%">1 (50.00%)<p style="text-align:center"></p></td> 
       <td class="acenter" width="29.88%">60 (69.77%)<p style="text-align:center"></p></td> 
       <td class="acenter" width="29.48%">24 (48.00%)<p style="text-align:center"></p></td> 
       <td class="acenter" width="30.16%">85 (61.59%)<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="acenter" width="29.54%">80 or more<p style="text-align:center"></p></td> 
       <td class="acenter" width="29.48%">0 (0.00%)<p style="text-align:center"></p></td> 
       <td class="acenter" width="29.88%">17 (19.77%)<p style="text-align:center"></p></td> 
       <td class="acenter" width="29.48%">11 (22.00%)<p style="text-align:center"></p></td> 
       <td class="acenter" width="30.16%">28 (20.29%)<p style="text-align:center"></p></td> 
      </tr> 
      <tr> 
       <td class="custom-bottom-td acenter" width="29.54%">Total<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="29.48%">2 (1.45%)<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="29.88%">86 (62.32%)<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="29.48%">50 (36.23%)<p style="text-align:center"></p></td> 
       <td class="custom-bottom-td acenter" width="30.16%">138 (100.00%)<p style="text-align:center"></p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
  </sec><sec id="s4">
   <title>4. Discussion</title>
   <p>In this study, the mean age at presentation was 68.88 ± 11.10 years. In Kumasi, Ghana, Aboah et al. found a mean age of 67.96 years among men who presented with lower urinary tract symptoms secondary to BPH <xref ref-type="bibr" rid="scirp.135385-9">
     [9]
    </xref>. Similar findings were reported by Ojewola and colleagues, in the south-western part of Nigeria <xref ref-type="bibr" rid="scirp.135385-10">
     [10]
    </xref>, and Zhang et al. in the Chinese population <xref ref-type="bibr" rid="scirp.135385-11">
     [11]
    </xref>. Thus patients are more likely to present with symptomatic BPH at age 60 years and above.</p>
   <p>Age has been reported as an important risk factor for the development and progression of lower urinary tract symptoms secondary to BPH <xref ref-type="bibr" rid="scirp.135385-12">
     [12]
    </xref> <xref ref-type="bibr" rid="scirp.135385-13">
     [13]
    </xref>. We found LUTS secondary to BPH prevalence among those aged 40 to 59 years to be 18.12%, and 61.59% among those aged 60 to 79 years.</p>
   <p>A majority of our study participants were from the Northern Region of Ghana (65.22%) where the study site is located making access easier. Also, the Northern Region has a greater population compared to the other regions in the northern part of Ghana, which this hospital serves <xref ref-type="bibr" rid="scirp.135385-14">
     [14]
    </xref>.</p>
   <p>The socioeconomic status of the study participants was generally low (83.33%) with a majority of them being uneducated. According to the Ghana Statistical Service in the 2010 Population and Housing Census, the proportions of the population, who have never been to school in the then three northern regions of Ghana ranged from 44.5 to 54.9 percent <xref ref-type="bibr" rid="scirp.135385-14">
     [14]
    </xref>. On the contrary, Chokkalingram et al. noted that about 77% percent of study participants with BPH had at least middle school education in the nation’s capital, Accra <xref ref-type="bibr" rid="scirp.135385-5">
     [5]
    </xref>. In Kumasi, also in southern Ghana, Gyasi-Sarpong et al. found that a majority of their study participants (58.67%) attained tertiary-level education, though most of them (57.78%) were pensioners <xref ref-type="bibr" rid="scirp.135385-15">
     [15]
    </xref>.</p>
   <p>Again the 2010 Population and Housing Census indicated that, the then three northern regions of Ghana had the highest poverty head count (44.2, 45.9 and 69.4, for the Northern, Upper East and Upper West Regions respectively), hence it is not surprising that the socio-economic level of this study’s participants was low <xref ref-type="bibr" rid="scirp.135385-14">
     [14]
    </xref>.</p>
   <p>BPH has been noted to be more prevalent in high-income groups <xref ref-type="bibr" rid="scirp.135385-16">
     [16]
    </xref>; however, Glynn and colleagues noted that patients with low socio-economic status were more likely to have surgery for BPH <xref ref-type="bibr" rid="scirp.135385-17">
     [17]
    </xref>. Perhaps, the low socio-economic status groups are more likely to present late to hospital hence they are more likely to have severe symptoms and complications such as obstructive uropathy, bladder stones and recurrent urinary tract infection, which are indications for surgery <xref ref-type="bibr" rid="scirp.135385-18">
     [18]
    </xref>. Those in the high socio-economic groups have better access to health care and are more likely to afford medications for the treatment of BPH compared to those in the low-income groups, hence the higher surgery rate in the low-income groups <xref ref-type="bibr" rid="scirp.135385-19">
     [19]
    </xref> <xref ref-type="bibr" rid="scirp.135385-20">
     [20]
    </xref>.</p>
   <p>Hypertension was the most common comorbidity among the participants in this study (31.20%). Those who had a combination of the components of the metabolic syndrome (diabetes mellitus, hypertension and hypercholesterinemia) formed 4.35%. Hypertension and benign prostatic hyperplasia are both diseases of the elderly and may commonly coexist. In one study, it was stated that approximately 30% of those treated with lower urinary tract symptoms due to BPH had hypertension <xref ref-type="bibr" rid="scirp.135385-21">
     [21]
    </xref>. Thus this current study is in conformity with what has been noted earlier.</p>
   <p>The relationship between components of metabolic syndrome including hypertension diabetes mellitus and hypercholesterinemia has been well established <xref ref-type="bibr" rid="scirp.135385-22">
     [22]
    </xref>-<xref ref-type="bibr" rid="scirp.135385-24">
     [24]
    </xref>. A retrospective study in Chinese patients with benign prostatic hyperplasia (BPH), found that BMI, fasting blood sugar, serum lipids and other components of metabolic syndrome had a positive correlation with prostate volume <xref ref-type="bibr" rid="scirp.135385-24">
     [24]
    </xref>. Similar findings were reported by Ryle et al. in Poland and Gacci in Italy <xref ref-type="bibr" rid="scirp.135385-22">
     [22]
    </xref> <xref ref-type="bibr" rid="scirp.135385-23">
     [23]
    </xref>.</p>
   <p>In several studies, prostate volume is positively associated with serum total PSA level <xref ref-type="bibr" rid="scirp.135385-25">
     [25]
    </xref>-<xref ref-type="bibr" rid="scirp.135385-27">
     [27]
    </xref>. In 1999, Roehrborn et al. found a strong correlation between serum prostate-specific antigen (PSA) levels and prostate volume <xref ref-type="bibr" rid="scirp.135385-25">
     [25]
    </xref>. Two years later he reported with other colleagues that in the absence of adenocarcinoma of the prostate, the PSA value may be used as a surrogate for prostate volume <xref ref-type="bibr" rid="scirp.135385-26">
     [26]
    </xref>. Similar report was made by Tsukamoto et al. in Japanese men <xref ref-type="bibr" rid="scirp.135385-27">
     [27]
    </xref>. The Spearman’s rho correlation of our study yielded a significant positive relationship between prostate volume and PSA (r = 0.383, p-value &lt; 0.001). This agrees with the above findings.</p>
   <p>Severe lower urinary tract symptoms were common in the age groups of 60 to 79 years (48.00%). This group had the largest representation in our study and hence may account for this finding. The older age group (80 years and above) in this study was represented by a little over twenty percent. Similarly in a Swedish study, 1.8% of patients from age 45 to 49 years had severe LUTS, while 9.7% of patients from age 75 to 79 years had severe LUTS <xref ref-type="bibr" rid="scirp.135385-28">
     [28]
    </xref>. Aging results in detrusor dysfunction and thus elderly men are more prone to developing lower urinary tract symptoms which may be worsened by bladder outlet obstruction due to BPH <xref ref-type="bibr" rid="scirp.135385-29">
     [29]
    </xref>.</p>
   <p>There is a lot of controversy surrounding the relationship between prostate volume and the severity of lower urinary tract symptoms in patients with BPH. About three decades ago Roehrborn et al. and Simonsen et al. reported that prostate volume did not correlate with symptom severity <xref ref-type="bibr" rid="scirp.135385-30">
     [30]
    </xref> <xref ref-type="bibr" rid="scirp.135385-31">
     [31]
    </xref>. Also, Ofoha et al. found that correlation between prostate volume and IPSS was not statistically significant using Pearson correlation in Nigeria <xref ref-type="bibr" rid="scirp.135385-32">
     [32]
    </xref>.</p>
   <p>Recently however a lot more studies are beginning to associate a large prostate volume with worse lower urinary tract symptoms, though most of them report only a weak association. <xref ref-type="bibr" rid="scirp.135385-33">
     [33]
    </xref>-<xref ref-type="bibr" rid="scirp.135385-35">
     [35]
    </xref>. However, in a study by Awaisu et al. in Nigeria, prostate volume correlated significantly with IPSS and Qmax on uroflowmetry <xref ref-type="bibr" rid="scirp.135385-36">
     [36]
    </xref>. Similarly, we found a positive correlation between prostate volume and IPSS (r = 0.334, p-value &lt; 0.001). Thus, for patients who will develop LUTS secondary to BPH, the size of the prostate is a determinant of the severity of symptoms.</p>
  </sec><sec id="s5">
   <title>5. Conclusion</title>
   <p>Our patients with LUTS secondary to BPH present at age 60 years and above with an average prostate volume of 70 g. The average time to presentation is 5 months mostly with moderate to severe symptoms.</p>
  </sec><sec id="s6">
   <title>6. Limitation</title>
   <p>There was a large number of uneducated participants in this study; hence their understanding of the questionnaire relating to the IPSS may have been impaired.</p>
  </sec><sec id="s7">
   <title>7. Recommendation</title>
   <p>It is recommended that further studies be carried out to ascertain the reasons for the delay in presentation of patients with BPH in our area, and the possible common complications that they develop as a result of the lower urinary tract obstruction.</p>
  </sec><sec id="s8">
   <title>Ethics Approval and Consent to Participate</title>
   <p>The study protocols were submitted to the Komfo Anokye Teaching Hospital Institutional Review Board for review. Ethical approval for the study was gotten from this institution after the review with number KATH-IRB/AP/071/20. We also got permission from the study site Tamale Teaching Hospital.</p>
   <p>All participants signed an informed consent before they were included in the study.</p>
  </sec><sec id="s9">
   <title>Consent for Publication</title>
   <p>Participants also consented to publication of this work with assurance that their names and contact details were not going to be part of the publication.</p>
  </sec><sec id="s10">
   <title>Availability of Data and Material</title>
   <p>The collected data is available though it will only be shared without participants’ names and contact details.</p>
  </sec><sec id="s11">
   <title>Funding</title>
   <p>The study was self-sponsored.</p>
  </sec><sec id="s12">
   <title>Authors’ Contributions</title>
   <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
    <tr> 
     <td class="aleft" width="16.60%">A.J.M.M<p style="text-align:left"></p></td> 
     <td class="aleft" width="83.40%">Design of study, data collection, analysis and writing up of manuscript<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft" width="16.60%">E.M.T.Y<p style="text-align:left"></p></td> 
     <td class="aleft" width="83.40%">Design of study and data collection<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft" width="16.60%">F.A.A<p style="text-align:left"></p></td> 
     <td class="aleft" width="83.40%">Revision of the manuscript<p style="text-align:left"></p></td> 
    </tr> 
   </table>
  </sec><sec id="s13">
   <title>List of Abbreviations</title>
   <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
    <tr> 
     <td class="aleft">BMI<p style="text-align:left"></p></td> 
     <td class="aleft">Body Mass Index<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft">WC<p style="text-align:left"></p></td> 
     <td class="aleft">Waist circumference<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft">BPH<p style="text-align:left"></p></td> 
     <td class="aleft">Benign Prostatic Hyperplasia<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft">IPSS<p style="text-align:left"></p></td> 
     <td class="aleft">International Prostate Symptom Score<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft">LUTS<p style="text-align:left"></p></td> 
     <td class="aleft">Lower Urinary Tract Symptoms<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft">QoL<p style="text-align:left"></p></td> 
     <td class="aleft">Quality of Life<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft">PSA<p style="text-align:left"></p></td> 
     <td class="aleft">Prostate-Specific Antigen<p style="text-align:left"></p></td> 
    </tr> 
    <tr> 
     <td class="aleft">SPSS<p style="text-align:left"></p></td> 
     <td class="aleft">Statistical Package for Social Sciences<p style="text-align:left"></p></td> 
    </tr> 
   </table>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.135385-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lowsley, O.S. (1912) The Development of the Human Prostate Gland with Reference to the Development of Other Structures at the Neck of the Urinary Bladder. American Journal of Anatomy, 13, 299-349. &gt;https://doi.org/10.1002/aja.1000130303
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Moore, K.L., Dalley, A.F. and Agur, A.M.R. (2013) Clinically Oriented Anatomy. 5th Edition, Lippincott Williams&amp;Wilkins. 
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Roehrborn, C.G. (2008) Pathology of Benign Prostatic Hyperplasia. International Journal of Impotence Research, 20, S11-S18. &gt;https://doi.org/10.1038/ijir.2008.55
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Roehrborn, C.G. (2005) Benign Prostatic Hyperplasia: An Overview. Reviews in Urology, 7, S3-S14.
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Chokkalingam, A.P., Yeboah, E.D., DeMarzo, A., Netto, G., Yu, K., Biritwum, R.B., et al. (2011) Prevalence of BPH and Lower Urinary Tract Symptoms in West Africans. Prostate Cancer and Prostatic Diseases, 15, 170-176. &gt;https://doi.org/10.1038/pcan.2011.43
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lee, S.W.H., Chan, E.M.C. and Lai, Y.K. (2017) The Global Burden of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. Scientific Reports, 7, Article No. 7984. &gt;https://doi.org/10.1038/s41598-017-06628-8
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Yeboah, E. (2016) Prevalence of Benign Prostatic Hyperplasia and Prostate Cancer in Africans and Africans in the Diaspora. Journal of West African College of Surgeons, 6, 1-30.
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ghana Statistical Service (2012) 2010 Population and Housing Census; Summary Report of Final Results. Ghana Statistical Service, Accra. 
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kenneth, A., Francis, A., Christian, G., Ferguson, L., Emmanuel, A., Benjamin, T., et al. (2016) Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia among Ghanaian Men: A Hospital-Based Cross-Sectional Prospective Study. International Journal of Research in Medical Sciences, 4, 3905-3911. &gt;https://doi.org/10.18203/2320-6012.ijrms20162906
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ojewola, R.W., Oridota, E.S., Balogun, O.S., Alabi, T.O., Ajayi, A.I., Olajide, T.A., et al. (2017) Prevalence of Clinical Benign Prostatic Hyperplasia Amongst Community-Dwelling Men in a South-Western Nigerian Rural Setting: A Cross-Sectional Study. African Journal of Urology, 23, 109-115. &gt;https://doi.org/10.1016/j.afju.2016.02.004
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zhang, J., Ma, M., Nan, X. and Sheng, B. (2016) Obesity Inversely Correlates with Prostate-Specific Antigen Levels in a Population with Normal Screening Results of Prostate Cancer in Northwestern China. Brazilian Journal of Medical and Biological Research, 49, e5272. &gt;https://doi.org/10.1590/1414-431x20165272
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Seim, A., Hoyo, C., Østbye, T. and Vatten, L. (2005) The Prevalence and Correlates of Urinary Tract Symptoms in Norwegian Men: The HUNT Study. BJU International, 96, 88-92. &gt;https://doi.org/10.1111/j.1464-410x.2005.05573.x
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Safarinejad, M.R. (2008) Prevalence of Benign Prostatic Hyperplasia in a Population-Based Study in Iranian Men 40 Years Old or Older. International Urology and Nephrology, 40, 921-931. &gt;https://doi.org/10.1007/s11255-008-9338-7
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ghana Statistical Service (2021) Ghana 2021 Population and Housing Census; Preliminary Report. 
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Acheampong, E., Gyasi-Sarpong, C., Yeboah, F., Aboah, K., Laing, E. and Amoah, G. (2018) Predictors of the International Prostate Symptoms Scores for Patients with Lower Urinary Tract Symptoms: A Descriptive Cross-Sectional Study. Urology Annals, 10, 317-323. &gt;https://doi.org/10.4103/ua.ua_4_17
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Araki, H., Watanabe, H., Mishina, T. and Nakao, M. (1983) High‐Risk Group for Benign Prostatic Hypertrophy. The Prostate, 4, 253-264. &gt;https://doi.org/10.1002/pros.2990040305
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Glynn, R.J., Campion, E.W., Bouchard, G.R. and Silbert, J.E. (1985) The Development of Benign Prostatic Hyerplasia among Volunteers in the Normative Aging Study. American Journal of Epidemiology, 121, 78-90.
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Hunter, D.J.W., Berra-Unamuno, A. and Martin-Gordo, A. (1996) Prevalence of Urinary Symptoms and Other Urological Conditions in Spanish Men 50 Years Old or Older. Journal of Urology, 155, 1965-1970. &gt;https://doi.org/10.1016/s0022-5347(01)66063-4
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Badia, X., Rodríguez, F., Carballido, J., García Losa, M., Unda, M., Dal-Ré, R., et al. (2001) Influence of Sociodemographic and Health Status Variables on the American Urological Association Symptom Scores in Patients with Lower Urinary Tract Symptoms. Urology, 57, 71-77. &gt;https://doi.org/10.1016/s0090-4295(00)00894-3
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Asare, G.A., Afriyie, D., Ngala, R.A., Appiah, A.A., Anang, Y., Musah, I., et al. (2015) Shrinkage of Prostate and Improved Quality of Life: Management of BPH Patients with Croton membranaceus Ethanolic Root Extract. Evidence-Based Complementary and Alternative Medicine, 2015, Article 365205. &gt;https://doi.org/10.1155/2015/365205
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Boyle, P. and Napalkov, P. (1996) Epidemiology of Benign Prostatic Hyperplasia: Current Perspectives. European Urology, 29, 7-11. &gt;https://doi.org/10.1159/000473814
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Rył, A., Rotter, I., Miazgowski, T., Słojewski, M., Dołęgowska, B., Lubkowska, A., et al. (2015) Metabolic Syndrome and Benign Prostatic Hyperplasia: Association or Coincidence? Diabetology&amp;Metabolic Syndrome, 7, Article No. 94. &gt;https://doi.org/10.1186/s13098-015-0089-1
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gacci, M., Sebastianelli, A., Salvi, M., De Nunzio, C., Vignozzi, L., Corona, G., et al. (2017) Benign Prostatic Enlargement Can Be Influenced by Metabolic Profile: Results of a Multicenter Prospective Study. BMC Urology, 17, Article No. 22. &gt;https://doi.org/10.1186/s12894-017-0211-9
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Pan, J.G., Jiang, C., Luo, R. and Zhou, X. (2013) Association of Metabolic Syndrome and Benign Prostatic Hyperplasia in Chinese Patients of Different Age Decades. Urologia Internationalis, 93, 10-16. &gt;https://doi.org/10.1159/000354026
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Roehrborn, C.G., Boyle, P., Gould, A.L. and Waldstreicher, J. (1999) Serum Prostate-Specific Antigen as a Predictor of Prostate Volume in Men with Benign Prostatic Hyperplasia. Urology, 53, 581-589. &gt;https://doi.org/10.1016/s0090-4295(98)00655-4
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Roehrborn, C.G., Malice, M., Cook, T.J. and Girman, C.J. (2001) Clinical Predictors of Spontaneous Acute Urinary Retention in Men with LUTS and Clinical BPH: A Comprehensive Analysis of the Pooled Placebo Groups of Several Large Clinical Trials. Urology, 58, 210-216. &gt;https://doi.org/10.1016/s0090-4295(01)01155-4
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tsukamoto, T., Masumori, N., Rahman, M. and Crane, M.M. (2007) Change in International Prostate Symptom Score, Prostrate‐Specific Antigen and Prostate Volume in Patients with Benign Prostatic Hyperplasia Followed Longitudinally. International Journal of Urology, 14, 321-324. &gt;https://doi.org/10.1111/j.1442-2042.2007.01596.x
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Andersson, S., Rashidkhani, B., Karlberg, L., Wolk, A. and Johansson, J. (2004) Prevalence of Lower Urinary Tract Symptoms in Men Aged 45-79 Years: A Population‐Based Study of 40 000 Swedish Men. BJU International, 94, 327-331. &gt;https://doi.org/10.1111/j.1464-410x.2004.04930.x
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref29">
    <label>29</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Resnick, N.M. (1987) Detrusor Hyperactivity with Impaired Contractile Function. JAMA, 257, 3076-3081. &gt;https://doi.org/10.1001/jama.1987.03390220074024
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref30">
    <label>30</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Roehrborn, C.G., Chinn, H.K.W., Fulgham, P.F., Simpkins, K.L. and Peters, P.C. (1986) The Role of Transabdominal Ultrasound in the Prostatic Hypertrophy. Journal of Urology, 135, 1190-1193. &gt;https://doi.org/10.1016/s0022-5347(17)46032-0
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref31">
    <label>31</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Simonsen, O., Møller-Madsen, B., Dørflinger, T., Nørgåard, J.P., Jørgensen, H.S. and Lundhus, E. (1987) The Significance of Age on Symptoms and Urodynamic-and Cystoscopic Findings in Benign Prostatic Hypertrophy. Urological Research, 15, 355-358. &gt;https://doi.org/10.1007/bf00265667
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref32">
    <label>32</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ofoha, C.G., Shu’aibu, S.I., Akpayak, I.C., Dakum, N.K. and Ramyil, V.M. (2015) Relationship between Prostate Volume and IPSS in African Men with Prostate Disease. Jos Journal of Medicine, 9, 16-19.
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref33">
    <label>33</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Barry, M.J., Cockett, A.T.K., Holtgrewe, H.L., McConnell, J.D., Sihelnik, S.A. and Winfield, H.N. (1993) Relationship of Symptoms of Prostatism to Commonly Used Physiological and Anatomical Measures of the Severity of Benign Prostatic Hyperplasia. Journal of Urology, 150, 351-358. &gt;https://doi.org/10.1016/s0022-5347(17)35482-4
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref34">
    <label>34</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bosch, J.L.H.R., Kranse, R., van Mastrigt, R. and Schroder, F.H. (1995) Reasons for the Weak Correlation between Prostate Volume and Urethral Resistance Parameters in Patients with Prostatism. Journal of Urology, 153, 689-693. &gt;https://doi.org/10.1016/s0022-5347(01)67687-0
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref35">
    <label>35</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Girman, C.J., Jacobsen, S.J., Guess, H.A., Oesterling, J.E., Chute, C.G., Panser, L.A., et al. (1995) Natural History of Prostatism: Relationship among Symptoms, Prostate Volume and Peak Urinary Flow Rate. Journal of Urology, 153, 1510-1515. &gt;https://doi.org/10.1016/s0022-5347(01)67448-2
    </mixed-citation>
   </ref>
   <ref id="scirp.135385-ref36">
    <label>36</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Awaisu, M., Ahmed, M., Lawal, A.T., Sudi, A., Tolani, M.A., Oyelowo, N., et al. (2021) Correlation of Prostate Volume with Severity of Lower Urinary Tract Symptoms as Measured by International Prostate Symptoms Score and Maximum Urine Flow Rate among Patients with Benign Prostatic Hyperplasia. African Journal of Urology, 27, Article No. 16. &gt;https://doi.org/10.1186/s12301-021-00122-4
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>